Pancytopenia presenting with monosomy 7 which disappeared after immunosuppressive therapy

Leukemia Research

Volumn 28, Issue 3, 2004, Pages 315-319

  Nagasawa, Masayuki ^a   Tomizawa, Daisuke ^a   Tsuji, Youichirou ^a   Kajiwara, Michiko ^a   Morio, Tomohiro ^a   Nonoyama, Shigeaki ^a   Asada, Minoru ^a   Mizutani, Shuki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Aplastic anemia; Cyclosporine A; Monosomy 7; WT1

Indexed keywords

CD34 ANTIGEN; CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; RNA; THYMOCYTE ANTIBODY; WT1 PROTEIN;

ARTICLE; BONE MARROW CELL; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; DYSPLASIA; FEMALE; HEMATOPOIESIS; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE COUNT; MONONUCLEAR CELL; MONOSOMY 7; MORPHOLOGY; PANCYTOPENIA; PERIPHERAL BLOOD MONONUCLEAR CELL; PETECHIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0347995087     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(03)00263-7     Document Type: Article

References (30)

1. Locatelli F., Zecca M., Pession A., Maserati E., De Stefano P., Severi F. Myelodysplastic syndromes: the pediatric point of view. Haematologica. 80:1995;268-279.
2. Luna-Fineman S., Shannon K.M., Atwater S.K., Davis J., Masterson M., Ortega J.et al. Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients. Blood. 93:1999;459-466.
3. Bader-Meunier B., Mielot F., Tchernia G., Buisine J., Delsol G., Duchayne E.et al. Myelodysplastic syndromes in childhood: report of 49 patients from a French multicentre study. Br. J. Haematol. 92:1996;344-350.
4. Hasle H., Arico M., Basso G., Biondi A., Rajnoldi A.C., Creutzig U.et al. Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7. Leukemia. 13:1999;376-385.
5. Hellstrom-Lindberg E. Treatment of adult myelodysplastic syndromes. Int. J. Hematol. 70:1999;141-154.
6. Kikuchi A, Ohashi H, Hanada R, Yamamoto K. Myelodysplastic syndrome (MDS) with unbalanced t(17) after severe aplastic anemia (SAA) in childhood as a variant form of monosomy 7. Leukemia.
7. Hasle H., Kerndrup G., Yssing M., Clausen N., Ostergaard E., Jacobsen N.et al. Intensive chemotherapy in childhood myelodysplastic syndrome. A comparison with results in acute myeloid leukemia. Leukemia. 10:1996;1269-1273.
8. Locatelli F., Pession A., Bonetti F., Maserati E., Prete L., Pedrazzoli P.et al. Busulfan, cyclophosphamide and melphalan as conditioning regimen for bone marrow transplantation in children with myelodysplastic syndrome. Leukemia. 8:1994;844-849.
9. Hasle H. Myelodysplastic syndromes in childhood-classification, epidemiology, and treatment. Leuk. Lymph. 13:1994;11-26.
10. Renneboog B., Hansen V., Heimann P., De Mulder A., Janssen F., Ferster A. Spontaneous remission in a patient with therapy-related myelodysplastic syndrome (tMDS) with monosomy 7. Br. J. Haematol. 92:1996;696-698.
11. Mantadakis E., Shannon K.M., Singer D.A., Finklestein J., Chan K.W., Hilden J.M.et al. Transient monosomy 7. A case series in children and review of the literature. Cancer. 85:1999;2655-2661.
12. Scheurlen W., Borkhardt A., Ritterbach J., Huppertz H.I. Spontaneous hematological remission in a boy with myelodysplastic syndrome and monosomy 7. Leukemia. 8:1994;1435-1438.
13. Laver J.H., Yusuf U., Cantu E.S., Barredo J.C., Holt L.B., Abboud M.R. Transient therapy related myelodysplastic syndrome associated with monosomy 7 and 11q23 translocation. Leukemia. 11:1997;448-455.
14. Kojima S., Hibi S., Kosaka Y., Yamamoto M., Tsuchida M., Mugishima H.et al. Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood. 96:2000;2049-2054.
15. Hashino S., Imamura M., Tanaka J., Kobayashi S., Musashi S., Kasai M.et al. Transformation of severe aplastic anemia into acute myelodysplastic leukemia with monosomy 7. Ann. Hematol. 72:1996;337-339.
16. Inoue K., Sugiyama H., Ogawa H., Nakagawa M., Yamagami T., Miwa H.et al. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood. 84:1994;3071-3079.
17. Arico M., Biondi A., Pui C.H. Juvenile myelomonocytic leukemia. Blood. 90:1997;479-488.
18. Shannon K.M., O'Connell P., Martin G., Paderanga D., Olson K., Dinndorf P.et al. Loss of the abnormal NF1 allele from the bone marrow of children with type1 neurofibromatosis and malignant myeloid disorders. New Engl. J. Med. 330:1994;597-601.
19. Largaespada D.A., Brannan C.I., Jenkins N.A., Copeland N.G. NF1 deficiency causes Ras-mediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukemia. Nat. Genet. 12:1996;137.
20. Tamaki H., Ogawa H., Ohyashiki K., Ohyashiki J.H., Iwama H., Inoue K.et al. The Wilm's tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndrome. Leukemia. 13:1999;393-399.
21. Sako M., Ogawa H., Okamura J., Tamaki H., Nakahata T., Kishimoto T.et al. Abnormal expression of the Wilm's tumor gene WT1 in juvenile chronic myeloid leukemia and infantile monosomy 7 syndrome. Leuk. Res. 22:1998;965-967.
22. Zoumbos N.C., Gascon P., Djeu J.Y., Trost S.R., Young N.S. Circulating activated suppressor T lymphocytes in aplastic anemia. New Engl. J. Med. 312:1985;257-265.
23. Piaggio G., Podesta M., Pitto A., Sessarego M., Figari O., Fugazza G.et al. Coexistence of normal and clonal haemopoiesis in aplastic anaemia patients treated with immunosuppressive therapy. Br. J. Haematol. 107:1999;505-511.
24. Ristiano A.M., Kook H., Zeng W., Chen G., Young N.S., Maciejewski J.P. Oligoclonal and polyclonal CD4 and CD8 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by Vβ CDR3 spectratyping and flow cytometry. Blood. 100:2002;178-183.
25. Ohga S., Ohara A., Hibi S., Kojima S., Bessho F., Tsuchida S.et al. Treatment responses of childhood aplastic anaemia with chromosomal aberrations at diagnosis. Br. J. Haematol. 118:2002;313-319.
26. Maciejewski J.P., Risitano A., Sloand E.M., Nunez O., Young N.S. Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia. Blood. 99:2002;3129-3135.
27. Ishiyama K., Karasawa M., Miyawaki S., Ueda Y., Noda M., Wakita A.et al. Aplastic anaemia with 13q-: a benign subset of bone marrow failure responsive to immunosuppressive therapy. Br. J. Haematol. 117:2002;747-750.
28. Robertson J.D., Gogvadze V., Zhivotovsky B., Orrenius S. Distinct pathways for stimulation of cytochrome c release. J. Biol. Chem. 275:2000;32438-32443.
29. Mancini M., Anderson B.O., Caldwell E., Sedghinasab M., Paty P.B., Hockenbery D.M. Mitochondrial proliferation and paradoxical membrane depolarization during terminal differentiation and apoptosis in a human colon carcinoma cell line. J. Cell. Biol. 138:1997;449-469.
30. Ito C., Ribeiro R.C., Behm F.G., Raimondi S.C., Pui C.H., Campana D. Cyclosporin A induces apoptosis in childhood acute lymphocytic leukemia cells. Blood. 91:1998;1001-1007.